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CASE REPORT
Lamotrigine for startle-induced seizures
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Startle-induced seizures are reflex seizures precipitated by a sudden, surprising stimulus, usually auditory. Aetiologies, elec-
troencephalographic correlates, and brain structural abnormalities are variable. Because of the frequent tonic component at
onset, falling is a major clinical problem. There is no established drug of choice, and therapy is often unsatisfactory. Adjunctive
lamotrigine therapy was used in four consecutive patients with this syndrome seen in a referral epilepsy practice. All four had
been refractory to virtually every other drug, but responded dramatically to lamotrigine with elimination of falls from seizures.
This observation may serve as pilot data for trials of lamotrigine for startle-induced or other varieties of reflex epilepsies, as
adjunctive or monotherapy.
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The phenomenon of startle-induced epileptic seizures
is uncommon but well described. The most common
triggering stimulus is a sudden noise1. Other sudden
and unexpected stimuli can also trigger seizures in
some patients with this form of reflex epilepsy. The
causes of this syndrome are heterogenous, but some
patients have focal neuroimaging abnormalities in the
frontal lobes1–3. Asymmetric tonic posturing is the
most common seizure type1. Most, but not all, patients
are mentally retarded1, 2.
Treatment of this syndrome is difficult. Some pa-
tients respond favorably to carbamazepine or val-
proate3. However, the lack of consistent response to
standard medications for partial onset seizures has led
to trials of less common agents, including clobazam4,
L-tryptophan5, and clonazepam6.
All of the newer antiepileptic drugs have been tested
first in patients with partial onset seizures because
these patients are the most numerous. The effects of a
drug on subcategories of partial onset seizures and rel-
atively uncommon syndromes are also worth knowing,
but often the number of available patients is too few to
mount a double-blind, placebo-controlled trial. Case
reports in specific syndromes may provide early indi-1059–1311/99/060361 + 03 $12.00/0cations of drug usefulness. Four consecutive patients
with intractable startle-induced seizures were treated
with lamotrigine with remarkable improvement.
CASE 1
A 19-year-old girl had developed seizures shortly af-
ter birth in a setting of Rh incompatibility, hemolytic
anemia, and cardiorespiratory arrest. Seizures, micro-
cephaly, a mild left hemiparesis, and moderate mental
retardation ensued. The seizures were easily provoked
in the clinic by hand clapping or door slamming. They
involved sudden extension of the head and left arm,
flexion of the right arm, extension of the legs, a groan,
and a fall. Despite trials of carbamazepine, pheny-
toin, phenobarbital, valproate, methsuximide and var-
ious combinations, she had several seizures daily and
had never gone more than 3 days without a seizure in
her life. Although most seizures were provoked, about
25% were spontaneous.
EEGs showed generalized slowing and neuroimag-
ing studies were normal.
When she was 18-years-old, lamotrigine was added
to a regimen of valproate 1250 mg and methsuximide
600 mg daily and was increased to 100 mg daily. Thec© 1999 BEA Trading Ltd
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later, the parents reported that she had had no spon-
taneous seizures, and no startle-induced seizures ‘un-
less she spits out her medicines’. They also noted an
improvement in alertness. Serum drug levels were not
measured because of her excellent control without side
effects.
CASE 2
A 24-year-old woman with mild mental retardation
had developed seizures at the age of 7. They were of
three types: (1) unilateral facial twisting and bilateral
eyelid blinking, (2) startle-induced seizures with sud-
den extension of the arms over the head, tonic exten-
sion of the legs, falling, and urination, and (3) occa-
sional generalized tonic–clonic events evolving from
one of these two types. Her best control was with a
combination of valproate and carbamazepine, but she
continued to have frequent daily seizures. Previous
medications were acetazolamide, clonazepam, pheny-
toin, felbamate, primidone, and clorazepate. She was
referred for consideration of corpus callosotomy.
EEGs were diffusely slow with interictal left frontal-
parietal sharp waves. Magnetic resonance imaging
demonstrated generalized atrophy of white matter and
areas of ulegyria with periventricular leukomalacia. Ic-
tal EEG recordings were not localizing.
When she was 21-years-old, lamotrigine was added
to a carbamazepine-valproate combination, and car-
bamazepine was withdrawn. A lamotrigine dose of
250 mg per day with a valproate dose of 1250 mg per
day was achieved, with lamotrigine levels of 10–
16 µg/ml. Valproate levels were held constant be-
fore and after lamotrigine addition. Falling to the
floor stopped, and she was able to discontinue helmet
wearing. Three years later, she remained free of falls
with seizures, although occasional brief head drops
with very loud noises occurred occasionally. Higher
lamotrigine doses and serum levels caused dizziness.
She was able to finish a high school special educa-
tion course because the school bells no longer caused
seizures. Improvements in alertness and mood were
apparent to her family and physician.
CASE 3
A 26-year-old woman developed seizures in the
neonatal period after an episode of hypoxia and hy-
poglycemia at birth. Seizures subsided until the age
of 11, when they recurred and became intractable. She
developed slowly and had a diagnosis of cerebral palsy
and moderate mental retardation. The seizures were ei-
ther hemiclonic jerking of the left side of the face andthe body, or ‘drop attacks’. The drop attacks were pre-
cipitated by loud noises, and began with flinging of
the arms to the side and falling backwards. She recov-
ered quickly but was confused for about 1 minute. At
the time of addition of lamotrigine, drop attacks were
occurring several times daily.
Generalized EEG slowing was observed, with no
definite change during the seizures. Neuroimaging
studies were normal except for platybasia and cerebel-
lar atrophy.
When she was 24-years-old, lamotrigine was added
to a schedule of carbamazepine 600 mg and valproate
1250 mg daily and was increased slowly over 8 weeks
to 75 mg daily. There was an immediate improve-
ment in seizure frequency, and at a lamotrigine dose
of 75 mg per day, she had only occasional jerks which
did not throw her to the ground in response to loud
noises. Unfortunately, 10 weeks after lamotrigine ther-
apy was started she developed blisters in the mouth
and the drug was stopped. Later trials of topiramate,
clonazepam, and tiagabine had no effect on her seizure
frequency, which had returned to a rate of several drop
attacks per day.
CASE 4
A 62-year-old woman of normal intelligence had a his-
tory of occasional falls to the ground when surprised
by a loud noise since early childhood. In her 20s, a
diagnosis of myoclonic epilepsy was made, though
EEGs were consistently normal. Dilantin and phe-
nobarbital were not completely effective. Valproate
worked best, but she gained weight, lost hair, and still
had seizures whenever the telephone rang and when
her husband blew his nose. She wrapped all her tele-
phones in towels. Nearly all seizures were noise in-
duced, but a surprise visual or touch stimulus rarely
caused an event. Uncommonly, she had one sponta-
neously in a setting of anxiety and preceded by a feel-
ing of tension building up in her right arm. Valproate
was stopped. Gabapentin and topiramate failed, and
lorazepam worsened seizures.
A typical event was precipitated in the clinic by
slamming the door: she simultaneously extended her
right leg, elevated and flexed her right arm, and ex-
tended her head, then relaxed after about 5 seconds.
Alteration of consciousness was not apparent. An EEG
was normal and an MRI scan displayed only mild gen-
eralized atrophy.
At age 61, lamotrigine was added to a regimen of
gabapentin 1800 mg and topiramate 300 mg daily and
increased over 30 days to a dose of 50 mg twice daily.
Seizure frequency decreased from 2–5 falls weekly to
none within 2 weeks of starting LTG. She has been
seizure free for 6 months and has unwrapped her tele-
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DISCUSSION AND CONCLUSIONS
The most dramatic and useful effect of lamotrigine
in these patients was prevention of the drop attacks
caused by the tonic component of the startle-induced
seizures. Although this was not a controlled study,
and lamotrigine was used only as an adjunctive agent,
the long history of refractory seizures causing falling
in each case and the rapid improvement with lamot-
rigine, together with the quick relapse in one patient
when lamotrigine was discontinued, are compelling
evidence that it was the effective factor in their seizure
control.
Each of these patients had been treated with val-
proate. Although they all had seizures of probable par-
tial onset, valproate had been the most useful drug
for all four patients. Nevertheless, they had all been
pushed to valproate clinical toxicity without satisfac-
tory control of the tonic component of the seizures.
It is possible that there was a synergistic effect in
three between lamotrigine and valproate, an effect
suggested for other groups of patients7–9. Valproate
greatly inhibits the metabolism of lamotrigine, and ex-
tremely low doses must be used initially. There is some
evidence that this combination does not produce more
allergic rashes than other combinations if lamotrigine
is added very slowly10. Even with appropriate caution,
rashes can occur, as in Case 3. In Case 4, lamotrigine
was added to topiramate and gabapentin and was ef-
fective at only 100 mg/day.
Each of these patients was being considered for cor-
pus callosotomy or vagal nerve stimulation at the time
lamotrigine was added. The three who were able to tol-
erate the drug are no longer falling, and therefore may
have been spared a procedure. Startle-induced seizure
patients often have widespread or nonlocalizing find-
ings on EEG and neuroimaging studies and are thus
not ideal candidates for focal surgical resections.
Lamotrigine has been demonstrated to be effective
in reducing drop attacks in the Lennox–Gastaut syn-
drome11, but those drop attacks are mostly axial tonic
or atonic and are considered to be of generalized on-set. These patients with startle-induced seizures ap-
peared to have partial-onset seizures. Perhaps the phe-
nomenon of the drop attack is a more important clue to
the selection of therapy than any apparent distinction
between generalized and partial seizure onsets.
In conclusion, lamotrigine is potentially useful for
the treatment of noise-related, startle-induced tonic
seizures and may prevent falling from this cause.
Comparisons to other drugs, placebo-controlled trials,
trials of monotherapy, and trials for other forms of re-
flex epilepsy would all be of interest. Formal trials may
be difficult because of the paucity of patients.
